Autonomix Medical Inc (AMIX)

$0.33 -0.01 (-1.64%)
Market Cap 2.32M
Revenue (ttm) 0.00
Net Income (ttm) -11.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 123,100
Avg Vol 134,352
Day's Range N/A - N/A
Shares Out 6.91M
Stochastic %K 11%
Beta -1.82
Analysts Strong Sell
Price Target $2.00

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices
Sector: Healthcare
Phone: 713 588 6150
Address:
21 Waterway Avenue, Suite 300, The Woodlands, United States
coolmate25
coolmate25 May. 12 at 8:04 PM
$AMIX Trust me, some really filthy son of a bitch-s dealing with this shit .
0 · Reply
dwhall5056
dwhall5056 May. 12 at 1:10 PM
$AMIX good shakeout - now maybe we can get some news so the stock can go up for a change.
0 · Reply
VinWeezel
VinWeezel May. 10 at 12:58 PM
$AMIX pump anytime soon? Volume? News? From digestive disease week? Seem to be afloat. Cmon Schwarz.
0 · Reply
coolmate25
coolmate25 May. 7 at 7:44 PM
$AMIX The entire stocks are up but this POS is still down , wonderful what kind of low life scum bags dealing with it .
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 4 at 8:18 PM
$AMIX RSI: 42.17, MACD: -0.0127 Vol: 0.02, MA20: 0.38, MA50: 0.40 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
VinWeezel
VinWeezel May. 2 at 3:59 PM
$AMIX it’s digestive disease week in Chicago!
0 · Reply
MrShort7
MrShort7 Apr. 30 at 11:47 AM
$AMIX just sit back and wait! No timeline!
1 · Reply
focafoca99
focafoca99 Apr. 29 at 2:14 PM
$AMIX announced abstract acceptance at Digestive Disease Week 2026 featuring long-term data in pancreatic cancer pain mitigation.
0 · Reply
VinWeezel
VinWeezel Apr. 29 at 12:53 PM
$AMIX https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-abstract-acceptance-at-digestive-disease-0b5roe0l5clo.html
1 · Reply
PrimeZoneNews
PrimeZoneNews Apr. 28 at 5:37 PM
$AMIX has been granted U.S. patent today, titled "Devices, systems, and methods for diagnosis and treatment of overactive bladder". Watch before close!😉
0 · Reply
Latest News on AMIX
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Apr 29, 2026, 8:45 AM EDT - 13 days ago

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Apr 22, 2026, 8:42 AM EDT - 20 days ago

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Apr 8, 2026, 8:40 AM EDT - 4 weeks ago

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Autonomix Medical to Present at LSI USA '26

Mar 11, 2026, 8:40 AM EDT - 2 months ago

Autonomix Medical to Present at LSI USA '26

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Mar 5, 2026, 8:45 AM EST - 2 months ago

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Autonomix to present clinical study on Nerve Neurolysis at CRT 2026

2026-03-04T13:46:28.000Z - 2 months ago

Autonomix to present clinical study on Nerve Neurolysis at CRT 2026

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

Mar 4, 2026, 8:40 AM EST - 2 months ago

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation

Feb 25, 2026, 8:30 AM EST - 2 months ago

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation

Autonomix selected to present new long-term pain mitigation data at SSO 2026

2026-02-19T13:48:07.000Z - 2 months ago

Autonomix selected to present new long-term pain mitigation data at SSO 2026

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

Feb 19, 2026, 8:30 AM EST - 2 months ago

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

Autonomix price target lowered to $2 from $5 at Maxim

2026-02-17T14:00:34.000Z - 3 months ago

Autonomix price target lowered to $2 from $5 at Maxim

Autonomix announces final clinical data on pain mitigation in pancreatic cancer

2026-01-28T13:45:46.000Z - 3 months ago

Autonomix announces final clinical data on pain mitigation in pancreatic cancer

Autonomix showcases PoC study clinical data at 2026 ASCO Symposium

2026-01-09T13:51:26.000Z - 4 months ago

Autonomix showcases PoC study clinical data at 2026 ASCO Symposium

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Jan 9, 2026, 8:45 AM EST - 4 months ago

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Autonomix granted European patent on nerve-targeted therapies technology

2025-12-30T13:40:37.000Z - 4 months ago

Autonomix granted European patent on nerve-targeted therapies technology

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Dec 23, 2025, 8:45 AM EST - 5 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Dec 18, 2025, 8:30 AM EST - 5 months ago

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Autonomix files to sell 13.5M shares of common stock for holders

2025-11-26T22:10:11.000Z - 5 months ago

Autonomix files to sell 13.5M shares of common stock for holders

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Nov 26, 2025, 8:45 AM EST - 5 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Autonomix prices 4.5M shares at $1.11 in private placement

2025-11-18T15:00:39.000Z - 6 months ago

Autonomix prices 4.5M shares at $1.11 in private placement

Autonomix reports results from exploratory subgroup analysis on PoC study

2025-11-17T13:15:20.000Z - 6 months ago

Autonomix reports results from exploratory subgroup analysis on PoC study

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 24, 2025, 9:00 AM EDT - 7 months ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Oct 16, 2025, 9:15 AM EDT - 7 months ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Autonomix granted U.S patent on platform enabling precision therapies

2025-10-09T12:50:09.000Z - 7 months ago

Autonomix granted U.S patent on platform enabling precision therapies

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 9, 2025, 8:45 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Oct 2, 2025, 8:45 AM EDT - 7 months ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Autonomix launches GLP study for Sensing and RF ablation system

2025-09-29T13:20:31.000Z - 8 months ago

Autonomix launches GLP study for Sensing and RF ablation system

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Sep 29, 2025, 9:15 AM EDT - 8 months ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Autonomix files to sell 2.5M shares of common stock for holders

2025-09-23T21:20:18.000Z - 8 months ago

Autonomix files to sell 2.5M shares of common stock for holders

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Sep 4, 2025, 9:00 AM EDT - 8 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Autonomix announces longer-term post hoc data from PoC 1 trial

2025-09-03T12:41:46.000Z - 8 months ago

Autonomix announces longer-term post hoc data from PoC 1 trial

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 3, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Autonomix files to sell 1.57M shares of common stock for holders

2025-08-20T21:05:09.000Z - 9 months ago

Autonomix files to sell 1.57M shares of common stock for holders

Autonomix granted new European patent for catheter-based technology

2025-08-20T12:45:20.000Z - 9 months ago

Autonomix granted new European patent for catheter-based technology

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 18, 2025, 9:15 AM EDT - 9 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 9:00 AM EDT - 9 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix finalizes design review of intravascular nerve sensing catheter

2025-08-14T12:41:02.000Z - 9 months ago

Autonomix finalizes design review of intravascular nerve sensing catheter

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Aug 14, 2025, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 22, 2025, 8:45 AM EDT - 10 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Autonomix announces exercise of warrants for $2.5M gross proceeds

2025-07-22T12:40:55.000Z - 10 months ago

Autonomix announces exercise of warrants for $2.5M gross proceeds

Autonomix granted new U.S. patent on smart torquer device

2025-07-21T12:53:24.000Z - 10 months ago

Autonomix granted new U.S. patent on smart torquer device

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Jul 21, 2025, 8:45 AM EDT - 10 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Autonomix releases next CEO Corner segment

2025-07-07T12:40:09.000Z - 11 months ago

Autonomix releases next CEO Corner segment

Autonomix announces first patient enrolled, treated in follow-on phase to POC 2

2025-06-30T14:24:36.000Z - 11 months ago

Autonomix announces first patient enrolled, treated in follow-on phase to POC 2

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 30, 2025, 8:30 AM EDT - 11 months ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 27, 2025, 8:00 AM EDT - 11 months ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Jun 5, 2025, 8:45 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 15, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 14, 2025, 9:20 AM EDT - 1 year ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 13, 2025, 9:20 AM EDT - 1 year ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 5, 2025, 8:30 AM EDT - 1 year ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

May 1, 2025, 9:25 AM EDT - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 5:00 PM EDT - 1 year ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 8, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Apr 3, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Mar 14, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 20, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 24, 2025, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 1 year ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

coolmate25
coolmate25 May. 12 at 8:04 PM
$AMIX Trust me, some really filthy son of a bitch-s dealing with this shit .
0 · Reply
dwhall5056
dwhall5056 May. 12 at 1:10 PM
$AMIX good shakeout - now maybe we can get some news so the stock can go up for a change.
0 · Reply
VinWeezel
VinWeezel May. 10 at 12:58 PM
$AMIX pump anytime soon? Volume? News? From digestive disease week? Seem to be afloat. Cmon Schwarz.
0 · Reply
coolmate25
coolmate25 May. 7 at 7:44 PM
$AMIX The entire stocks are up but this POS is still down , wonderful what kind of low life scum bags dealing with it .
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 4 at 8:18 PM
$AMIX RSI: 42.17, MACD: -0.0127 Vol: 0.02, MA20: 0.38, MA50: 0.40 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
VinWeezel
VinWeezel May. 2 at 3:59 PM
$AMIX it’s digestive disease week in Chicago!
0 · Reply
MrShort7
MrShort7 Apr. 30 at 11:47 AM
$AMIX just sit back and wait! No timeline!
1 · Reply
focafoca99
focafoca99 Apr. 29 at 2:14 PM
$AMIX announced abstract acceptance at Digestive Disease Week 2026 featuring long-term data in pancreatic cancer pain mitigation.
0 · Reply
VinWeezel
VinWeezel Apr. 29 at 12:53 PM
$AMIX https://www.stocktitan.net/news/AMIX/autonomix-medical-announces-abstract-acceptance-at-digestive-disease-0b5roe0l5clo.html
1 · Reply
PrimeZoneNews
PrimeZoneNews Apr. 28 at 5:37 PM
$AMIX has been granted U.S. patent today, titled "Devices, systems, and methods for diagnosis and treatment of overactive bladder". Watch before close!😉
0 · Reply
RISE07
RISE07 Apr. 24 at 10:56 PM
$AMIX Hoping it will reach $1.00 Before July 13
1 · Reply
coolmate25
coolmate25 Apr. 23 at 7:36 PM
$AMIX Yet another small news lol ! Wish they get some investment before big news.
0 · Reply
coolmate25
coolmate25 Apr. 22 at 7:40 PM
$AMIX All that news still not enough, we really need that De-novo Clarence.
0 · Reply
focafoca99
focafoca99 Apr. 22 at 6:41 PM
$AMIX will present long-term pancreatic cancer pain mitigation data at ECIO 2026.
0 · Reply
coolmate25
coolmate25 Apr. 22 at 2:33 PM
$AMIX Don't know what the fck is going on today ? Hoping for late pickup .
0 · Reply
dwhall5056
dwhall5056 Apr. 22 at 1:08 PM
$AMIX Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 ... https://ir.autonomix.com/autonomix-medical-to-present-long-term-pain-mitigation-data-in-pancreatic-cancer-at-ecio-2026/
1 · Reply
VinWeezel
VinWeezel Apr. 22 at 12:36 PM
$AMIX yikes?
0 · Reply
coolmate25
coolmate25 Apr. 14 at 5:15 PM
$AMIX Same old sh-t every single day , seems like there is someone keep pumping dumping on low level , with their low level mentality.
1 · Reply
dwhall5056
dwhall5056 Apr. 14 at 2:47 PM
$AMIX face it, this stock has been good for bearish scalpers for a while now. Sure hoping for the kind of news that will give it a good bullish trajectory soon.
0 · Reply
coolmate25
coolmate25 Apr. 13 at 6:17 PM
$AMIX A little bit going up ? That's me buying lol and low life pos living in dumpsters taking it lol 😆.
0 · Reply
coolmate25
coolmate25 Apr. 10 at 8:05 PM
$AMIX I bought more today but there are some low life SOBs that has parasitic DNA keep fckn it up. Soon the shorts squeeze will bury their souls forever . Amin
0 · Reply
coolmate25
coolmate25 Apr. 9 at 3:16 PM
$AMIX According to Robinhood, the borrow rate is kinda high with less short flow and some elevated short interest so this upcoming news can well (if early) can hit the stock high. Imo so what are your options?
0 · Reply